OncologyStem cells and cancer

Stem cells and cancer
<p>Salvador Aznar-Benitah</p>
Group Leader

ICREA Research Professor, ERC Starting Grant

+34 93 40 34021

Adult stem cells ensure maintenance of the tissue and integrity in response to damage. They self-renew, are multipotential, and respond to and repair injuries. The skin and other stratified epithelia as model tissues display a high turnover rate, and contain well-defined populations of adult stem cells (SCs). A key feature of SCs is that they localize to specialized niches, where they remain unspecified but sense the needs of the tissue. Constant tissue replenishment drives a SCs to proliferate, the daughter cells to egress the niche, propagate, and terminally differentiate. Niche adherence, dormancy, activation, and exit, must be finely regulated processes, since loss of this tight control is causative of aging, and the onset and progression of squamous cell carcinomas.

Our global aim is to characterize the molecular pathways that regulate the behaviour of normal stem cells during homeostasis, and how they become deregulated during carcinogenesis and ageing.

stem cells

Epidermal stem cells from mouse tail skin visualized by wholemount 3D immunostaining: Left panel shows epidermal stem cells marked with BrDU (Label Retaining Cells); Middle and right panels Show expression of keratin-15 and high expression of integrin alpha6, respectively.

We are interested in studying the following questions:

  • What intrinsic (cell autonomous) mechanisms regulate adult stem cell function, and how are they deregulated during ageing and cancer?
  • How do adult stem cells communicate with their local environment (i.e. niche) and how is the system coordinated to dictate stem cell function?
  • What systemic cues communicate with adult stem cells and how do distant adult stem cells either from the same tissue or from different tissues coordinate their function at the level of the whole organism?
  • How does deregulation of pathways that control stem cell behaviour contribute to the maintenance and invasive progression of skin and oral squamous cell carcinomas (SCC)? Is there cancer stem cell heterogeneity in human SCC? If so, what is its significance?

We use a combination of conditional mouse models, primary cell culture (human and mouse), live microscopy, highthroughput genomics and proteomics approaches, and basic molecular biology.

Pascual G, Avgustinova A, Mejetta S, Martín M, Castellanos A, Attolini CS, Berenguer A, Prats N, Toll A, Hueto JA, Bescós C, Di Croce L and Benitah SA.
Nature, (2016)
Janich P, Toufighi K, Solanas G, Luis NM, Minkwitz S, Serrano L, Lehner B and Benitah SA.
Cell Stem Cell, 13 (6), 745-53 (2013)
Luis N, Morey L, Di Croce L, Benitah SA
Cell Stem Cell, 1 (11), 16-21 (2012)

This group is financially supported by the following:

  • Ministerio de Economía y Competitividad (MINECO)
  • European Commission (EC), Fondo Europeo de Desarrollo Regional (FEDER), "Una manera de hacer Europa"

     

Group news & mentions

18 Feb 2017

Gloria Pascual, Research Associate in the Stem Cells and Cancer Laboratory at IRB Barcelona, has been invited to participate in an open debate on cancer research, organised by the TV programme 'La

17 Feb 2017

Salvador Aznar Benitah, ICREA researcher at IRB Barcelona, has been awarded the 2016 "Premi Ciutat de Barcelona" in its Life Sciences category.

12 Feb 2017

“La Vanguardia” newspaper publishes an interview with Salvador Aznar-Benitah and Gloria Pascual, from the Stem Cells and Cancer Lab at IRB Barcelona, who have been nominated for the La Vanguardia S

<p>Salvador Aznar Benitah, Group Leader of the Stem Cell and Cancer Lab at IRB Barcelona.</p>
3 Feb 2017

The Barcelona City Council has announced the 2016 "Premi Ciutat de Barcelona" awardees, the highest recognition that the city gives to its citizens.

Upcoming events

23 Feb
Aula Fèlix Serratosa, Parc Científic de Barcelona
Speaker:
Toni Celià-Terrassa, PhD. Department of Molecular Biology, Princenton University, NJ (USA)
24 Feb
Sala Fèlix Serratosa, Parc Científic de Barcelona
Speaker:
Dr. Fanni Gergely, Cancer Research UK Cambridge Institute, University of Cambridge, UK
27 Feb
Aula Fèlix Serratosa, Parc Científic de Barcelona
Speaker:
Prof. Dr. Donghan Lee, BioNMR Group. Brown Cancer Center University of Louisville. Department of Medicine, University of Louisville, USA